Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
resverlogix |
Title | Home - Resverlogix |
Description | Phase 3 COVID-19 Clinical Trial – About Overview Team Partnership Strategy Governance Science & Programs BETonMACE Epigenetics Apabetalone Clinical Publications Investors Financial Reports |
Keywords | N/A |
WebSite | resverlogix.com |
Host IP | 159.203.49.164 |
Location | United States |
Site | Rank |
US$5,717,456
Last updated: 2023-05-10 06:23:20
resverlogix.com has Semrush global rank of 1,851,226. resverlogix.com has an estimated worth of US$ 5,717,456, based on its estimated Ads revenue. resverlogix.com receives approximately 659,707 unique visitors each day. Its web server is located in United States, with IP address 159.203.49.164. According to SiteAdvisor, resverlogix.com is safe to visit. |
Purchase/Sale Value | US$5,717,456 |
Daily Ads Revenue | US$5,278 |
Monthly Ads Revenue | US$158,330 |
Yearly Ads Revenue | US$1,899,955 |
Daily Unique Visitors | 43,981 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
resverlogix.com. | A | 1200 | IP: 159.203.49.164 |
resverlogix.com. | NS | 1200 | NS Record: dns1.easydns.com. |
resverlogix.com. | NS | 1200 | NS Record: dns2.easydns.net. |
resverlogix.com. | NS | 1200 | NS Record: dns3.easydns.org. |
resverlogix.com. | MX | 600 | MX Record: 20 mx2-us1.ppe-hosted.com. |
resverlogix.com. | MX | 600 | MX Record: 10 mx1-us1.ppe-hosted.com. |
resverlogix.com. | TXT | 3600 | TXT Record: MS=D14A6A4D0D571CDAC60BF5702D42B4CC20DEAC5D |
resverlogix.com. | TXT | 3600 | TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com ~all |
About Overview Team Partnership Strategy Governance Science & Programs BETonMACE Epigenetics Apabetalone Clinical Publications Investors Financial Reports News Presentations & Events Articles & Media Featured Stories From the Archives Contact General Careers RVX $0.15 +$0.01 Phase 3 COVID-19 Clinical Trial – CORAL Resverlogix and EVERSANA™ announce FDA Type C meeting for Phase 3 study CORAL in high-risk COVID-19 outpatients Learn More The Future of Drug Development Lead cardiovascular drug, apabetalone, receives Breakthrough Therapy designation from the US FDA Learn More Leading the Development of Modern Medicine Resverlogix, a global leader in developing safe, epigenetic therapeutics for people suffering from chronic illnesses Learn More Science & Programs Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions to key partners. Apabetalone The world leader in a new class |
HTTP/1.1 301 Moved Permanently Server: openresty/1.11.2.2 Date: Tue, 02 Nov 2021 07:21:02 GMT Content-Type: text/html Content-Length: 191 Connection: keep-alive Location: https://www.resverlogix.com/ HTTP/2 200 server: openresty/1.11.2.2 date: Tue, 02 Nov 2021 07:21:02 GMT content-type: text/html; charset=UTF-8 set-cookie: PHPSESSID=r50km2j040odhri09nb31dpok1; path=/ expires: Tue, 02 Nov 2021 08:21:36 GMT cache-control: max-age=3600, must-revalidate pragma: no-cache vary: Accept-Encoding x-provider: nonfiction studios inc. x-proxy-cache: BYPASS |
Domain Name: RESVERLOGIX.COM Registry Domain ID: 88957194_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.easydns.com Registrar URL: http://www.easydns.com Updated Date: 2020-06-22T22:28:57Z Creation Date: 2002-08-01T21:47:03Z Registry Expiry Date: 2023-08-01T21:47:03Z Registrar: easyDNS Technologies Inc. Registrar IANA ID: 469 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.EASYDNS.COM Name Server: NS2.EASYDNS.COM Name Server: NS3.EASYDNS.ORG Name Server: NS6.EASYDNS.NET Name Server: REMOTE1.EASYDNS.COM Name Server: REMOTE2.EASYDNS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-20T15:29:50Z <<< |